Altimmune
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Altimmune and other ETFs, options, and stocks.About ALT
Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH.
ALT Key Statistics
Stock Snapshot
As of today, Altimmune(ALT) shares are valued at $5.65. The company's market cap stands at 703.8M, with a P/E ratio of -5.24.
On 2026-02-02, Altimmune(ALT) stock moved within a range of $5.00 to $5.66. With shares now at $5.65, the stock is trading +13.0% above its intraday low and -0.1% below the session's peak.
Trading activity shows a volume of 6.28M, compared to an average daily volume of 6.97M.
The stock's 52-week range extends from a low of $2.90 to a high of $7.73.
The stock's 52-week range extends from a low of $2.90 to a high of $7.73.
ALT News
Altimmune ( (ALT) ) has shared an announcement. On January 27, 2026, Altimmune, Inc. entered into a Securities Purchase Agreement with a new fundamental instit...
Altimmune (ALT) has raised $75 million in new funding, giving the biotech company a boost as it continues developing its experimental obesity drug, pemvidutide....
Altimmune (ALT) “intends to use the net proceeds to fund preparation for its upcoming Phase 3 trial in metabolic dysfunction-associated steatohepatitis as well...
Analyst ratings
80%
of 10 ratingsMore ALT News
Barclays initiated coverage of Altimmune (ALT) with an Overweight rating and $20 price target Barclays initiated coverage of 12 biotech stocks and assumed cover...
Advertisement FDA Breakthrough designation puts pemvidutide in focus Altimmune (ALT) has drawn fresh attention after the FDA granted Breakthrough Therapy Desi...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.